Immune checkpoint inhibitors for high-risk non-muscle invasive bladder cancer: Lessons learnt from the CREST and POTOMAC trials. Gonzalez-Padilla DA, Subiela JD, Villacampa-Auba F. J Urol 2025 Nov 25:101097JU0000000000004864. doi: 10.1097/JU.0000000000004864.

Read + Share

Amedeo Smart

Independent Medical Education

Gonzalez-Padilla DA, Subiela JD, Villacampa-Auba F. Immune checkpoint inhibitors for high-risk non-muscle invasive bladder cancer: Lessons learnt from the CREST and POTOMAC trials. J Urol 2025 Nov 25:101097JU0000000000004864. doi: 10.1097/JU.0000000000004864.
PMID: 41289515